2023 Tennessee Code › Title 39 - CRIMINAL OFFENSES (§§ 39-1-101 — 39-17-1812) › Chapter 17 - OFFENSES AGAINST PUBLIC HEALTH, SAFETY AND WELFARE (§§ 39-17-101 — 39-17-1812) › Part 4 - DRUGS (§§ 39-17-401 — 39-17-456) › Section 39-17-406 - Controlled substances in Schedule I

(a)
Schedule I consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.
(b)
Opiates, unless specifically excepted or unless listed in another schedule, means any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; provided, that for the purposes of subdivision (b)(48)(B)(xv), 3-Methylfentanyl, only, "isomer" includes the optical and geometric isomers:
(1)
Acetylmethadol;
(2)
Allylprodine;
(3)
Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol; levomethadyl acetate; or LAAM);
(4)
Alphameprodine;
(5)
Alphamethadol;
(6)
Benzethidine;
(7)
Betacetylmethadol;
(8)
Betameprodine;
(9)
Betamethadol;
(10)
Betaprodine;
(11)
Clonitazene;
(12)
Dextromoramide;
(13)
Diampromide;
(14)
Diethylthiambutene;
(15)
Difenoxin;
(16)
Dimenoxadol;
(17)
Dimepheptanol;
(18)
Dimethylthiambutene;
(19)
Dioxaphetyl butyrate;
(20)
Dipipanone;
(21)
Ethylmethylthiambutene;
(22)
Etonitazene;
(23)
Etoxeridine;
(24)
Furethidine;
(25)
Hydroxypethidine;
(26)
Ketobemidone;
(27)
Levomoramide;
(28)
Levophenacylmorphan;
(29)
Morpheridine;
(30)
MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(31)
Noracymethadol;
(32)
Norlevorphanol;
(33)
Normethadone;
(34)
Norpipanone;
(35)
PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
(36)
Phenadoxone;
(37)
Phenampromide;
(38)
Phenomorphan;
(39)
Phenoperidine;
(40)
Piritramide;
(41)
Proheptazine;
(42)
Properidine;
(43)
Propiram;
(44)
Racemoramide;
(45)
Tilidine;
(46)
Trimeperidine;
(47)
U-47700; or
(48)
Fentanyl derivatives and analogues:
(A)
Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States food and drug administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations containing a 4-anilidopiperidine structure:
(i)
With or without substitution at the carbonyl of the aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl, methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl, dihydrofuranyl, benzyl moiety, or rings containing heteroatoms sulfur, oxygen, or nitrogen;
(ii)
With or without substitution at the piperidine amino moiety with a phenethyl, benzyl, alkylaryl (including heteroaromatics), alkyltetrazolyl ring, or an alkyl or carbomethoxy group, whether or not further substituted in the ring or group;
(iii)
With or without substitution or addition to the piperdine ring to any extent with one or more methyl, carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester groups;
(iv)
With or without substitution of one or more hydrogen atoms for halogens, or methyl, alkyl, or methoxy groups, in the aromatic ring of the anilide moiety;
(v)
With or without substitution at the alpha or beta position of the piperidine ring with alkyl, hydroxyl, or methoxy groups;
(vi)
With or without substitution of the benzene ring of the anilide moiety for an aromatic heterocycle; or
(vii)
With or without substitution of the piperidine ring for a pyrrolidine ring, perhydroazepine ring, or azepine ring; and
(B)
The application of subdivision (b)(48)(A) includes, but is not limited to, any of the following:
(i)
Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
(ii)
Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidnyl]-N-phenyl-acetamide);
(iii)
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide);
(iv)
Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);
(v)
Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(vi)
Benzodioxolefentanyl;
(vii)
Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(viii)
Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide); N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide);
(ix)
Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
(x)
Butyrylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
(xi)
Cyclopentyl fentanyl;
(xii)
Isobutyryl fentanyl;
(xiii)
Furanyl fentanyl;
(xiv)
Lofentanil;
(xv)
3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
(xvi)
3-Methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(xvii)
Ocfentanil;
(xviii)
Ohmefentanyl;
(xix)
Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide);
(xx)
Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; 4-fluoroisobutyryl fentanyl;
(xxi)
Pentanoyl fentanyl;
(xxii)
Thiofentanyl; or
(xxiii)
Valeryl fentanyl.
(c)
Opium derivatives, unless specifically excepted or unless listed in another schedule, means any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1)
Acetorphine;
(2)
Acetyldihydrocodeine;
(3)
Benzylmorphine;
(4)
Codeine methylbromide;
(5)
Codeine-N-Oxide;
(6)
Cyprenorphine;
(7)
Desomorphine;
(8)
Dihydromorphine;
(9)
Drotebanol;
(10)
Etorphine (except hydrochloride salt);
(11)
Heroin;
(12)
Hydromorphinol;
(13)
Methyldesorphine;
(14)
Methyldihydromorphine;
(15)
Morphine methylbromide;
(16)
Morphine methylsulfonate;
(17)
Morphine-N-Oxide;
(18)
Myrophine;
(19)
Nicocodeine;
(20)
Nicomorphine;
(21)
Normorphine;
(22)
Pholcodine; or
(23)
Thebacon.
(d)
Hallucinogenic substances, unless specifically excepted or unless listed in another schedule, means any material, compound mixture, or preparation that contains any quantity of the following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation; provided, that for purposes of this subsection (d) only, "isomer" includes the optical, positional, and geometric isomers:
(1)
Alpha-ethyltryptamine
Other names: etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; [alpha]-ET; and AET; ET; Trip;
(2)
Alpha-methyltryptamine
Other name: AMT;
(3)
4-Bromo-2,5-dimethoxyamphetamine
Other names: 4-Bromo-2,5-dimethoxy-[alpha]-methylphenethylamine; 4-bromo-2,5-DMA;
(4)
4-Bromo-2,5-dimethoxyphenethylamine
Other names: 2-(4-Bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B; Nexus;
(5)
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36;
(6)
Bufotenine
Other names: 3-([beta]-Dimethylaminoethyl)-5-hydroxyindole; 3-(2 dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
(7)
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82;
(8)
Diethyltryptamine
Other names: N,N-Diethyltryptamine; DET;
(9)
2,5-Dimethoxyamphetamine
Other names: 2,5-Dimethoxy-[alpha]-methylphenethylamine; 2,5-DMA;
(10)
2,5-Dimethoxy-4-ethylamphetamine
Other name: DOET;
(11)
2,5 Dimethoxy-4-(n)-propylthiophenethylamine
Other name: 2C-T-7;
(12)
Dimethyltryptamine
Other name: DMT;
(13)
Ethylamine analogue of phencyclidine
Other names: N-Ethyl-1-phenylcyclohexylamine; (1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE;
(14)
Ibogaine
Other names: 7-Ethyl-6,6[beta],7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1',2':1,2]azepino[5,4-b]indole; Tabenanthe iboga;
(15)
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Other names: 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5;
(16)
Lysergic acid diethylamide
Other name: LSD;
(17)
Mescaline
Other name: Constituent of "Peyote" cacti;
(18)
4-Methoxyamphetamine
Other names: 4-methoxy-[alpha]-methylphenethylamine; paramethoxyamphetamine; PMA;
(19)
5-Methoxy-3,4-methylenedioxyamphetamine;
(20)
5-Methoxy-N,N-diisopropyltryptamine
Other name: 5-MeO-DIPT;
(21)
5-methoxy-N,N-dimethyltryptamine
Other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT;
(22)
4-Methyl-2,5-dimethoxyamphetamine
Other names: 4-methyl-2,5-dimethoxy-[alpha]-methylphenethylamine; DOM; STP;
(23)
3,4-Methylenedioxyamphetamine;
(24)
3,4-Methylenedioxymethamphetamine
Other name: MDMA;
(25)
3,4-Methylenedioxy-N-ethylamphetamine
Other names: N-ethyl-alpha-methyl 3,4(methylenedioxy) phenethylamine; N-ethyl MDA; MDE; MDEA;
(26)
3,4-Methylenedioxy-N-methylcathinone
Other name: Methylone;
(27)
N-Ethyl-3-piperidyl benzilate;
(28)
N-Hydroxy-3,4-methylenedioxyamphetamine
Other names: N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-hydroxy MDA;
(29)
N-methyl-3-piperidyl benzilate;
(30)
Parahexyl
Other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
(31)
Peyote
Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lamaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant or its seeds or extracts (Interprets
21 U.S.C. § 812(c)
, Schedule l(c)(12));
(32)
Psilocybin (constituent of magic mushrooms);
(33)
Psilocyn (constituent of magic mushrooms);
(34)
Pyrrolidine analogue of phencyclidine (1-(1-phenylcyclohexyl)-pyrrolidine)
Other names: PCPy; PHP;
(35)
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
Other name: TCPy;
(36)
4-Methylmethcathinone
Other names: mephedrone; methpadrone; 4-MMC;
(37)
3,4-Methylenedioxypyrovalerone
Other name: MDPV;
(38)
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);
(39)
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);
(40)
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);
(41)
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);
(42)
2-[4-Ethylthio-2,5-dimethoxyphenyl]ethanamine (2C-T-2);
(43)
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);
(44)
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);
(45)
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);
(46)
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);
(47)
Thiophene analogue of phencyclidine
Other names: 1-[1-(2-thienyl)cyclohexyl]piperidine; 2-thienylanalog of phencyclidine; TPCP; TCP;
(48)
3,4,5-Trimethoxyamphetamine;
(49)
(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
Other names: UR-144; 1-pentyl-3-(2,2,3,3 tetramethylcyclopropoyl)indole; or
(50)
[1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone
Other names: 5-fluoro-UR-144; 5-F-UR-144; XLR-11 1-(5-fluoro-pentyl)-3- (2,2,3,3-tetramethylcyclopropoyl)indole.
(e)
Depressants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation:
(1)
Etizolam
Other names: Etilaam, Etizola, Sedekopan, Pasaden, Depas;
(2)
Gamma-hydroxybutyric acid
Other names: GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate;
(3)
Mecloqualone; or
(4)
Methaqualone.
(f)
Stimulants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
(1)
Alpha-pyrrolidinobutiophenone
Other names: [alpha]-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one;
(2)
Alpha-pyrrolidinopentiophenone
Other names: [alpha]-PVP; [alpha]-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one;
(3)
Aminorex
Other names: aminoxophen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine;
(4)
Butylone
Other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one;
(5)
Cathinone
Other names: 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone; 2-aminopropiophenone; norphedrone; constituent of catha edulis or "Khat" plant;
(6)
3-Fluoro-N-methylcathinone
Other names: 3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one;
(7)
4-Fluoro-N-methylcathinone
Other names: 4-FMC; flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1-one;
(8)
Fenethylline;
(9)
Methcathinone
Other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR1432;
(10)
(+/-)cis-4-Methylaminorex (cis isomer)
Other name: (+/-)cis-4,5 dihydro-4-methyl-5-phenyl-2-oxazolamine;
(11)
4-Methyl-N-ethylcathinone
Other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one;
(12)
4-Methyl-alpha-pyrrolidinopropiophenone
Other names: 4-MePPP; MePPP; 4-methyl-[alpha]-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one;
(13)
Naphyrone
Other names: naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one;
(14)
N-Benzylpiperazine
Other names: BZP; 1-benzylpiperazine;
(15)
N-Ethylamphetamine;
(16)
N,N-Dimethylamphetamine
Other names: N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine;
(17)
Pentedrone
Other names: [alpha]-methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one; or
(18)
Pentylone
Other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one.
(g)
Cannabimimetic agents, unless specifically exempted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances, or that contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1)
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);
(2)
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);
(3)
1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);
(4)
1-Butyl-3-(1-naphthoyl)indole (JWH-073);
(5)
1-Hexyl-3-(1-naphthoyl)indole (JWH-019);
(6)
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);
(7)
1-Pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);
(8)
1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);
(9)
1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);
(10)
1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);
(11)
(1-(5-Fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ-2201);
(12)
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
(13)
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
(14)
1-Pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);
(15)
1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8);
(16)
1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH-203);
(17)
Methyl 2-(1-(cyclohexylmethyl)-1h-indole-3-carboxamido)-3,3-dimethylbutanoate
Other names: MDMB-CHMICA, MMB-CHMINACA;
(18)
Methyl 2-(1-(4-fluorobenzyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate
Other name: MDMB-FUBINACA;
(19)
Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3-methylbutanoate
Other name: 5F-AMB;
(20)
Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate
Other names: 5F-ADB, 5F-MDMB-PINACA;
(21)
N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide
Other names: APINACA; AKB48;
(22)
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
Other names: 5F-APINACA, 5F-AKB48;
(23)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
Other name: AB-FUBINACA;
(24)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3-carboxamide
Other name: AB-CHMINACA;
(25)
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)1H-indazole-3-carboxamide
Other name: ADB-FUBINACA;
(26)
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
Other name: ADB-PINACA;
(27)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
Other name: AB-PINACA;
(28)
Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
Other names: 5-fluoro-PB-22; 5F-PB-22; or
(29)
Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate
Other names: PB-22; QUPIC.
Amended by 2018 Tenn. Acts, ch. 1040,s 3, eff. 7/1/2018.
Amended by 2015 Tenn. Acts, ch. 302,s 1, eff. 7/1/2015.
Amended by 2014 Tenn. Acts, ch. 735,s 2, eff. 7/1/2014.
Acts 1989, ch. 591, § 1; 1997, ch. 107, § 1; 1997, ch. 149, § 1; 2007, ch. 298, §§ 1-4; 2012, ch. 812, § 1.